Radiosensitization and a Less Aggressive Phenotype of Human Malignant Glioma Cells Expressing Isocitrate Dehydrogenase 1 (IDH1) Mutant Protein: Dissecting the Mechanisms.
IDH1
IDH1R132H
atomic force microscopy
cell stiffness
glioblastoma
glioma
isocitrate dehydrogenase 1
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Jun 2019
25 Jun 2019
Historique:
received:
29
03
2019
revised:
09
06
2019
accepted:
11
06
2019
entrez:
28
6
2019
pubmed:
28
6
2019
medline:
28
6
2019
Statut:
epublish
Résumé
The presence of an isocitrate dehydrogenase 1 (IDH1) mutation is associated with a less aggressive phenotype, increased sensitivity to radiation, and increased overall survival in patients with diffuse glioma. Based on in vitro experimentations in malignant glioma cell lines, the consequences on cellular processes of IDH1
Identifiants
pubmed: 31242696
pii: cancers11060889
doi: 10.3390/cancers11060889
pmc: PMC6627228
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Brain Pathol. 1999 Jul;9(3):469-79
pubmed: 10416987
J Cell Biol. 1999 Sep 6;146(5):905-16
pubmed: 10477747
J Theor Biol. 1999 Nov 7;201(1):63-74
pubmed: 10534436
Radiother Oncol. 1999 Nov;53(2):127-31
pubmed: 10665789
Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
pubmed: 10959836
Nature. 2000 Nov 9;408(6809):239-47
pubmed: 11089981
Semin Oncol. 2001 Apr;28(2 Suppl 8):29-35
pubmed: 11395850
Semin Oncol. 2001 Apr;28(2 Suppl 8):36-41
pubmed: 11395851
Free Radic Biol Med. 2002 Jun 1;32(11):1185-96
pubmed: 12031902
Exp Cell Res. 2002 Aug 1;278(1):92-100
pubmed: 12126961
Radiat Res. 2002 Oct;158(4):486-92
pubmed: 12236816
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5057-62
pubmed: 12679524
Biochem Cell Biol. 2003 Jun;81(3):123-9
pubmed: 12897845
Br J Radiol. 1953 Dec;26(312):638-48
pubmed: 13106296
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Radiother Oncol. 2005 Oct;77(1):18-24
pubmed: 16098619
J Biol Chem. 2006 Oct 13;281(41):30593-602
pubmed: 16912049
Wien Med Wochenschr. 2006 Jun;156(11-12):332-7
pubmed: 16944363
Nat Rev Mol Cell Biol. 2007 Jan;8(1):37-48
pubmed: 17183359
J Pharm Sci. 2007 Sep;96(9):2181-96
pubmed: 17593552
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
PLoS One. 2007 Aug 01;2(8):e690
pubmed: 17668068
Antioxid Redox Signal. 2008 Feb;10(2):179-206
pubmed: 18020963
Curr Biol. 2008 Apr 8;18(7):471-80
pubmed: 18372178
Nat Nanotechnol. 2007 Dec;2(12):780-3
pubmed: 18654431
N Engl J Med. 2008 Jul 31;359(5):492-507
pubmed: 18669428
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Hum Mutat. 2009 Jan;30(1):7-11
pubmed: 19117336
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Science. 2009 Apr 10;324(5924):261-5
pubmed: 19359588
Acta Neuropathol. 2009 Oct;118(4):469-74
pubmed: 19554337
J Clin Oncol. 2009 Sep 1;27(25):4150-4
pubmed: 19636000
Biophys J. 2009 Oct 7;97(7):1873-82
pubmed: 19804717
Ann Ist Super Sanita. 2009;45(3):265-71
pubmed: 19861731
Neurology. 2009 Nov 24;73(21):1792-5
pubmed: 19933982
BMC Cancer. 2010 Jan 05;10:4
pubmed: 20051134
Acta Neuropathol. 2010 Apr;119(4):487-94
pubmed: 20127344
Oncologist. 2010;15(2):196-9
pubmed: 20133500
J Exp Med. 2010 Feb 15;207(2):339-44
pubmed: 20142433
Clin Cancer Res. 2010 Mar 1;16(5):1597-604
pubmed: 20160062
Cancer Cell. 2010 Mar 16;17(3):225-34
pubmed: 20171147
Nat Rev Cancer. 2010 May;10(5):319-31
pubmed: 20414201
J Natl Cancer Inst. 2010 Jul 7;102(13):932-41
pubmed: 20513808
Ann Oncol. 2010 May;21 Suppl 5:v190-3
pubmed: 20555079
Nature. 2010 Jun 17;465(7300):966
pubmed: 20559394
Mol Biol Cell. 2010 Oct 1;21(19):3362-75
pubmed: 20702585
Acta Neuropathol. 2010 Nov;120(5):585-92
pubmed: 20862485
Cell Death Differ. 2011 Apr;18(4):666-77
pubmed: 21072054
Cell Adh Migr. 2011 Mar-Apr;5(2):170-80
pubmed: 21178402
Cancer Cell. 2011 Jan 18;19(1):17-30
pubmed: 21251613
Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3270-5
pubmed: 21289278
J Histochem Cytochem. 2011 May;59(5):489-503
pubmed: 21527585
Clin Cancer Res. 2011 Jul 1;17(13):4588-99
pubmed: 21558404
Cancer Res. 2011 Aug 1;71(15):5075-80
pubmed: 21642375
Cell. 2011 Jun 24;145(7):1012-22
pubmed: 21703446
Nanotechnology. 2008 Sep 24;19(38):384003
pubmed: 21832563
Nature. 2011 Nov 20;481(7381):380-4
pubmed: 22101433
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19611-6
pubmed: 22106302
J Cancer Res Clin Oncol. 2012 May;138(5):859-66
pubmed: 22297840
Pigment Cell Melanoma Res. 2012 May;25(3):375-83
pubmed: 22360810
J Biol Chem. 2012 Apr 27;287(18):14615-20
pubmed: 22442146
Cell. 2012 Mar 30;149(1):36-47
pubmed: 22464322
J Cell Sci. 2012 Apr 15;125(Pt 8):1855-64
pubmed: 22544950
Radiat Environ Biophys. 1990;29(4):273-92
pubmed: 2281134
Genes Dev. 2012 Sep 15;26(18):2038-49
pubmed: 22925884
Neuro Oncol. 2013 Jan;15(1):57-68
pubmed: 23115158
Mol Biol Cell. 2013 Jan;24(1):21-30
pubmed: 23115305
Clin Cancer Res. 2013 Feb 15;19(4):764-72
pubmed: 23209033
J Cancer Res Clin Oncol. 2013 May;139(5):739-46
pubmed: 23354842
Science. 2013 May 3;340(6132):626-30
pubmed: 23558169
Radiother Oncol. 2013 Jul;108(1):132-5
pubmed: 23932193
FASEB J. 2014 Feb;28(2):715-29
pubmed: 24347609
Mol Clin Oncol. 2013 Nov;1(6):935-941
pubmed: 24649273
Ann Oncol. 2014 Sep;25 Suppl 3:iii93-101
pubmed: 24782454
Biochim Biophys Acta. 2014 Dec;1846(2):326-41
pubmed: 24880135
Oncol Lett. 2014 Jun;7(6):1895-1902
pubmed: 24932255
Nat Rev Neurosci. 2014 Jul;15(7):455-65
pubmed: 24946761
Biophys J. 2014 Jul 15;107(2):314-323
pubmed: 25028873
Neuro Oncol. 2014 Oct;16 Suppl 4:iv1-63
pubmed: 25304271
Dev Cell. 2015 Jan 12;32(1):54-67
pubmed: 25543281
Acta Neuropathol. 2015 Apr;129(4):585-96
pubmed: 25701198
Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):332-44
pubmed: 25837899
Pharmacol Ther. 2015 Aug;152:54-62
pubmed: 25956465
J Mech Behav Biomed Mater. 2015 Sep;49:105-11
pubmed: 26004036
Cell Rep. 2015 Jun 16;11(10):1511-8
pubmed: 26027931
N Engl J Med. 2015 Jun 25;372(26):2481-98
pubmed: 26061751
Acta Neuropathol. 2015 Sep;130(3):407-17
pubmed: 26087904
Radiother Oncol. 2015 Sep;116(3):381-7
pubmed: 26328938
Cancer Res. 2015 Nov 15;75(22):4790-802
pubmed: 26363012
Exp Cell Res. 2016 Apr 10;343(1):14-20
pubmed: 26519907
Int J Biochem Cell Biol. 2016 Apr;73:72-81
pubmed: 26860959
Handb Clin Neurol. 2016;134:71-95
pubmed: 26948349
Elife. 2016 Mar 11;5:e10860
pubmed: 26971564
Cell Adh Migr. 2017 Jan 2;11(1):54-67
pubmed: 27149140
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Cancer Res. 2017 Feb 15;77(4):960-970
pubmed: 27923831
Cancer Res. 2017 Apr 1;77(7):1709-1718
pubmed: 28202508
Oncotarget. 2017 Apr 25;8(17):28865-28879
pubmed: 28427200
Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150
pubmed: 28815663
Neurosurgery. 2017 Sep 1;64(CN_suppl_1):134-138
pubmed: 28899049
Elife. 2017 Sep 26;6:
pubmed: 28949297
AJNR Am J Neuroradiol. 2018 Jan;39(1):31-36
pubmed: 29074637
Cells. 2017 Nov 22;6(4):null
pubmed: 29165393
Physiol Rev. 2018 Jan 1;98(1):215-238
pubmed: 29212790
Cell Rep. 2018 Jan 9;22(2):512-522
pubmed: 29320744
Front Microbiol. 2018 Feb 28;9:360
pubmed: 29541069
J Cell Biol. 2018 Sep 3;217(9):3031-3044
pubmed: 29980627
Nature. 2019 Jan;565(7738):240-245
pubmed: 30568303
Genome Biol. 2019 Feb 13;20(1):33
pubmed: 30760294
Mol Ther Oncolytics. 2018 Dec 31;12:147-161
pubmed: 30775418
Acta Pathol Microbiol Scand A. 1973 Nov;81(6):791-805
pubmed: 4359449